Biomarin Pharmaceutical
Price & Volume
Stats
See moreOpen | $57.05 |
Previous Close | $55.66 |
Day Range | $55.83-$57.37 |
52W Range | $49.26-$70.98 |
Market Cap | $11.1B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $3.4B |
Revenue Growth (YoY) | 19.9% |
Gross Profit (12 Mos) | $1.7B |
Diluted EPS | $0.36 |
News
See moreYahoo Finance • 15 hours ago
BioMarin Pharmaceutical Inc (BMRN) Q3 2026 Earnings Call Highlights: First $1 Billion Revenue ...
Yahoo Finance • 2 days ago
BioMarin anticipates $3.8B-$3.9B 2026 revenue while flagging $70M order deferrals
Yahoo Finance • 3 days ago
BioMarin Pharmaceutical (BMRN) Q3 earnings: what to expect
Yahoo Finance • last month
The Strategic Financial Case for BioMarin Pharmaceutical (BMRN)
About
CEO | Mr. Alexander Hardy |
CFO | Mr. Brian R. Mueller CPA |
Address | 770 Lindaro Street, San Rafael, CA, United States, 94901 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 3,221 |